Human Milk Oligosaccharides Market worth $570.55 million by 2030, growing at a CAGR of 9.56% - Exclusive Report by 360iResearch

The "Human Milk Oligosaccharides Market by Product (2'-Fucosyllactose(2'FL), 3'-Fucosyllactose (3'FL), 3'-Sialyllactose (3'SL)), Type (Acidic, Neutral), Application - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

The Global Human Milk Oligosaccharides Market to grow from USD 274.78 million in 2022 to USD 570.55 million by 2030, at a CAGR of 9.56%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/human-milk-oligosaccharides?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Human milk oligosaccharides (HMOs) are a mixed group of complex carbohydrates naturally present in human breast milk. They represent human milk's third enormous solid component after lactose and fat. As non-digestible food ingredients, HMOs serve multiple functions that contribute to the advantageous effects of human milk on infant health and development. HMOs play a critical role in developing an infant's gut microbiota, acting as prebiotics by selectively encouraging the development of beneficial bacteria, including Bifidobacteria and Lactobacillus. This helps establish a healthy intestinal environment that supports nutrient absorption and protects against pathogenic bacteria. Additionally, their utilization extends into functional foods and dietary supplements owing to their prebiotic and anti-pathogenic properties. HMOs are also studied for therapeutic potentials in gastroenterology, immunology, and oncology. The market is driven by the scientific consensus on the advantages of breastfeeding and the rising awareness of the benefits of HMOs. Technological advancements in the synthesis and extraction of HMOs contribute to market expansion. A growing infant formula industry, rising health concerns, and increasing purchasing power contributed significantly to the HMO market's growth. However, the growth of HMOs is hampered by high research and development costs associated with HMO production, regulatory challenges, the requirement for extensive safety evaluations before approvals, and the complexity of synthesizing HMOs that are identical to the ones found in human milk. On the other hand, the latest potential opportunities in the HMO market include the development of new and more cost-effective extraction and synthesis methods for a broader range of HMO compounds. Another area of opportunity lies in expanding the applications beyond dietary supplements and infant nutrition, particularly in gut health, immunity boosters, and therapeutic agents. Collaboration with healthcare institutions for clinical trials and academic institutions for research can create opportunities for market players.

The United States holds a significant share of the global HMOs market, driven by robust R&D initiatives and consumer awareness regarding infant nutrition. The region has witnessed growing demand for HMO-enhanced infant formula, attributed to the increasing need for nutritionally rich alternatives to breast milk. In Canada, consumer interest in advanced nutritional compositions for infants, including HMO-supplemented formulas, is growing. However, the market is just budding, and consumer purchasing behavior tends to lean toward trusted brands and scientifically backed products. The market for HMOs in South America is in a developing stage. Countries such as Brazil and Argentina are increasingly demanding advanced infant nutrition products. The European Union presents a mature market for HMOs, with a strong focus on infant nutrition and well-being. Countries such as Denmark and Germany are leading in terms of HMO research and production. EU regulations are stringent on product safety and quality, requiring companies to undergo rigorous evaluations. This has led to a customer base that is well-informed and discerning. While the market for HMOs is less pronounced in the Middle East and Africa, there is a noticeable increase in demand tied to rising incomes and an emerging middle class. Interest in advanced nutritional formulas for infants is growing, although the awareness and understanding of HMOs benefits are still developing. The APAC region is witnessing a rapid increase in demand for HMOs, particularly in countries such as India, China, and Japan. China has quickly become a primary market for HMOs in Asia, with national policies endorsing breastfeeding and higher-quality infant formula. Japan is known for its high standards in food safety and quality, which extends to the HMO market. Japanese consumers are health-conscious and show readiness to adopt scientifically-supported products, contributing to a steady demand for HMO-supplemented formulas. India is seen as an emerging market with vast potential for HMOs due to its large population and increasing focus on nutritional security. The awareness of the importance of early childhood nutrition is on the rise, and companies aim to capture this market by scaling up investment and promoting informed consumer behavior.

Market Segmentation & Coverage:

This research report categorizes the Human Milk Oligosaccharides Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across 2'-Fucosyllactose(2'FL), 3'-Fucosyllactose (3'FL), 3'-Sialyllactose (3'SL), 6'-Sialyllactose (6'SL), Lacto-n-neotetraose (LNnT), and Lacto-n-tetraose (LNT). The 2'-Fucosyllactose(2'FL) commanded largest market share of 33.19% in 2022, followed by Lacto-n-neotetraose (LNnT).

Based on Type, market is studied across Acidic and Neutral. The Neutral commanded largest market share of 79.11% in 2022, followed by Acidic.

Based on Application, market is studied across Functional Food & Supplements, Infant Formulas, and Laboratory Research. The Functional Food & Supplements commanded largest market share of 47.60% in 2022, followed by Infant Formulas.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 48.68% in 2022, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/human-milk-oligosaccharides?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Human Milk Oligosaccharides Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Human Milk Oligosaccharides Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Human Milk Oligosaccharides Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Protein Technologies Corp., Agilent Technologies, Inc., BASF SE, Biosynth AG, Chr. Hansen Holding A/S, Conagen, Inc., Dextra Laboratories Ltd, DuPont de Nemours, Inc., Elicityl SA, Glycosyn LLC, Gnubiotics Sciences SA, Inbiose NV, Kirin Holdings Company, Limited, Koninklijke DSM N.V., Laïta Nutrition, Lonza Group AG, Nestlé S.A., Roquette Frères, Royal FrieslandCampina N.V., Tate & Lyle PLC, TurtleTree, and ZuChem, Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Human Milk Oligosaccharides Market, by Product
7. Human Milk Oligosaccharides Market, by Type
8. Human Milk Oligosaccharides Market, by Application
9. Americas Human Milk Oligosaccharides Market
10. Asia-Pacific Human Milk Oligosaccharides Market
11. Europe, Middle East & Africa Human Milk Oligosaccharides Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Human Milk Oligosaccharides Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Human Milk Oligosaccharides Market?
3. What is the competitive strategic window for opportunities in the Human Milk Oligosaccharides Market?
4. What are the technology trends and regulatory frameworks in the Human Milk Oligosaccharides Market?
5. What is the market share of the leading vendors in the Human Milk Oligosaccharides Market?
6. What modes and strategic moves are considered suitable for entering the Human Milk Oligosaccharides Market?

Read More @ https://www.360iresearch.com/library/intelligence/human-milk-oligosaccharides?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.